Innovative and Professional: Viracta Therapeutics to Cease Operations
Viracta Therapeutics, Inc. Announces Termination of Employees SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers, has made a significant announcement today. The company has decided to terminate its employees and will wind down its operations. Additionally, they…